Westside Investment Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Westside Investment Management’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$8	Buy	+165	New	+$8.16K	﹤0.01%	502
2018 Q4	$7.74K	Buy	+165	New	+$8.46K	﹤0.01%	514
2018 Q3	–	Sell	-165	Closed	-$8.31K	–	765
2018 Q2	$8.31K	Hold	165	–	–	﹤0.01%	600
2018 Q1	$7.8K	Hold	165	–	–	﹤0.01%	594
2017 Q4	$8.58K	Hold	165	–	–	﹤0.01%	600
2017 Q3	$8.73K	Hold	165	–	–	0.01%	581
2017 Q2	$8.48K	Hold	165	–	–	0.01%	575
2017 Q1	$8.23K	Buy	+165	New	+$8.17K	﹤0.01%	552

Other funds holding IHE

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Biegel & Waller Columbia, Maryland $179M AUM 1.6% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Westside Investment Management's IHE Position: Q2 2019 in Review

Westside Investment Management opened a new position in iShares US Pharmaceuticals ETF (IHE) in Q2 2019: 165 shares worth $8. The stake represents ﹤0.01% of the portfolio and ranks #502 among its holdings. This is a return to the name: Westside Investment Management previously reported a position in IHE as recently as Q4 2018.

Westside Investment Management first reported a position in IHE in Q1 2017 and has held it in 8 quarters since. The position peaked at $8.73K in Q3 2017. 87 funds tracked by Wall St. Rank hold IHE as of Q2 2019.

Westside Investment Management held 165 shares of iShares US Pharmaceuticals ETF worth $8 as of Q2 2019.
iShares US Pharmaceuticals ETF was a new Westside Investment Management position in Q2 2019.
iShares US Pharmaceuticals ETF made up ﹤0.01% of Westside Investment Management's portfolio in Q2 2019, its #502 holding.
Westside Investment Management first reported a position in iShares US Pharmaceuticals ETF in Q1 2017 and has held it in 8 quarters since.
Westside Investment Management's iShares US Pharmaceuticals ETF position peaked at $8.73K in Q3 2017.
87 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2019.

Based on Westside Investment Management's 13F filing for Q2 2019, filed 24 Jul 2019.